Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11363-11369
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Table 1 Clinical characteristics of 235 consecutive liver transplant patients
| Variables | Value | |
| Age (yr) | 47.11 ± 11.32 | |
| MELD score | 16 (range 6-50) | |
| Child score | 9 (range 5-15) | |
| Gender | Male | 203 (86.4) |
| Female | 32 (13.6) | |
| Etiology | HBV-related | 140 (59.6) |
| Hepatocarcinoma | 55 (23.4) | |
| Others | 40 (17) | |
| Blood tests | Bilirubin (μmol/L) (NR < 17.1) | 162.73 ± 205.39 |
| AST (IU/L) (NR < 50) | 240.46 ± 556.16 | |
| ALT (IU/L) (NR < 40) | 183.2 ± 325.93 | |
| Albumin (g/L) (NR 35-50) | 34.96 ± 5.47 | |
| WBC (× 109/L) (NR 3.5-11) | 5.96 ± 4.58 | |
| Urea (mmol/L) (NR 3-7.1) | 6.70 ± 5.29 | |
| Creatinine (μmol/L) (NR 60-97) | 94.37 ± 68.98 | |
| TC | 7.91 ± 2.28 | |
| ABO | A-A | 85 (36.2) |
| B-B | 51 (21.7) | |
| O-O | 87 (37) | |
| AB-AB | 12 (5.1) |
Table 2 Clinical Fk506-related side effects and cause of death
| All events (n) | First events only (n) | |
| Rejection | 38 | 20 |
| Infection | 55 | 26 |
| Renal insufficiency | 7 | 2 |
| Tumor recurrence | 36 | 18 |
| Metabolic disorder | 34 | 21 |
| Cause of death | ||
| MODS | 11 | |
| Tumor recurrence | 22 | |
| Graft loss | 3 | |
| Others | 11 |
Table 3 Classification of groups according to mean tacrolimus concentration, death rate and related side effects in respective categories
| Group | 1 | 2 | 3 | 4 |
| TC interval (ng/mL) | 0-5 | 5-7 | 7-10 | 10-15 |
| Total number | 21 | 57 | 119 | 38 |
| Number of death | 8 | 9 | 23 | 7 |
| Cause of death | ||||
| MODS | 4 | 4 | 2 | 1 |
| Tumor recurrence | 2 | 4 | 13 | 3 |
| Graft loss | 1 | 1 | 0 | 1 |
| Others | 1 | 0 | 8 | 2 |
| Rejection | 2 | 14 | 16 | 6 |
| Infection | 6 | 14 | 24 | 11 |
| Renal insufficiency | 2 | 2 | 2 | 1 |
| Tumor recurrence | 5 | 7 | 19 | 5 |
| Metabolic disorder | 6 | 8 | 15 | 5 |
Table 4 Classification of groups according to standard deviation of Tacrolimus concentration, death rate and related side effects in respective categories
| Group | 1 | 2 | 3 |
| SD interval | 0-2 | 2-4 | > 4 |
| Total number | 21 | 118 | 96 |
| Number of death | 7 | 18 | 22 |
| Cause of death | |||
| MODS | 4 | 4 | 3 |
| Tumor recurrence | 2 | 7 | 13 |
| Graft loss | 0 | 2 | 1 |
| Others | 1 | 5 | 5 |
| Rejection | 1 | 21 | 16 |
| Infection | 5 | 25 | 25 |
| Renal insufficiency | 0 | 6 | 1 |
| Tumor recurrence | 3 | 14 | 19 |
| Metabolic disorder | 2 | 20 | 12 |
Table 5 Variables in multivariate Cox regression equation of long-term survival
| B | SE | Wald | df | Sig. | Exp(B) | Lower | Upper | |
| Gender | -0.809 | 0.352 | 5.284 | 1 | 0.022 | 0.445 | 0.224 | 0.888 |
| Age | 0.252 | 0.612 | 0.170 | 1 | 0.680 | 1.287 | 0.388 | 4.273 |
| Plug score | 0.640 | 0.364 | 3.093 | 1 | 0.079 | 1.897 | 0.929 | 3.870 |
| Meld score | -0.281 | 0.266 | 1.113 | 1 | 0.291 | 0.755 | 0.448 | 1.272 |
| Diagnosis | -0.351 | 0.162 | 4.691 | 1 | 0.030 | 0.704 | 0.512 | 0.967 |
| SD of TC | 0.345 | 0.153 | 5.063 | 1 | 0.024 | 1.412 | 1.045 | 1.907 |
| Mean TC | -0.960 | 0.397 | 5.830 | 1 | 0.016 | 0.383 | 0.176 | 0.835 |
- Citation: Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11363
